<DOC>
	<DOCNO>NCT00643474</DOCNO>
	<brief_summary>This randomize , parallel study compare 2 group type 2 non-insulin treat ( NIT ) diabetes patient use Accu-Chek Aviva glucometers . One group ( Intensive Group ) perform 4-point daily glucose monitoring profile 3 time week Monnier-based . These patient also receive specific glycemic target suggestion reach follow lifestyle recommendation . At time , investigator use SMBG result , download glucometers , improve patient ' therapy . The second group ( Control Group ) , follow SMBG standard care usually adopt center . To eligible , patient perform previous intensive SMBG management ( execution SMBG measurement use modify lifestyle , diet physical activity , systematic/structured manner and/or manage therapeutic approach ) . The anticipated duration trial 12 month , target sample size 1000 individual .</brief_summary>
	<brief_title>PRISMA Study ( Prospective , Randomized Trial Intensive Self-Monitoring Blood Glucose Management Added Value Non-Insulin Treated Type 2 Diabetes Mellitus Patients )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Adult patient , 3575 year age Noninsulin treat type 2 diabetes 110 year enrollment Treatment diet oral hypoglycemic agent , diet HbAlc 7.09.0 % Type 1 diabetes Insulin treatment ( &amp; gt ; 7 consecutive day ) Previous intensive SMBG management ( execution SMBG measurement use modify lifestyle , diet physical activity systemic/structured manner and/or manage therapeutic approach ) impend complication diabetes ; serious disease , include cardiovascular damage limit life expectancy ; pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>